Board-certified neuro-oncologist and medical oncologist Manmeet Ahluwalia, M.D., FACP, M.B.A., joins Baptist Health’s Miami Cancer Institute, as deputy director, chief scientific officer and chief of solid tumor medical oncology. Board-certified in internal medicine, medical oncology, neuro-oncology and hematology, Dr. Ahluwalia is a leading expert in brain metastases and primary brain tumors. He is fluent in English, Hindi and Punjabi.
“I would like to welcome Dr. Ahluwalia to Miami Cancer Institute,” said Leonard Kalman, M.D., executive deputy director and chief medical officer at Miami Cancer Institute. “As deputy director, chief scientific officer and chief of solid tumor medical oncology, we are confident that the innovation that he will bring to our clinical trials efforts will benefit our patients and enhance the reputation of our Institute.”
Dr. Ahluwalia joins Miami Cancer Institute from the Cleveland Clinic, where he was the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology and the head of operations in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center (BBTC). He also served as a professor in the Department of Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.
Dr. Ahluwalia's research focuses on the development of new therapies for patients with brain tumors and brain metastases. He is an internationally recognized clinical investigator with deep ties in both the established and start-up pharmaceutical community, both of which have led to his role as principal investigator on many multi-site national and international studies involving many solid tumor types. His research has been presented nationally and internationally and has resulted in over 200 manuscripts, editorials and book chapters.
Dr. Ahluwalia has served in multiple leadership positions in professional societies and serves in editorial capacities for several journals. He has been the recipient of numerous prestigious awards, such as the National Cancer Institute/ CTEP Career Development Award for Clinical Trial in American Brain Tumor Consortium (ABTC), American Society of Clinical Oncology (ASCO) Leadership Development Program award, Crain’s 40 Under 40 award and has been nominated to the Leading in Healthcare, Cleveland Clinic.
Dr. Ahluwalia earned his medical degree from Maulana Azad Medical College, University of Delhi. He completed his internal medicine residency at Cleveland Clinic Health System and hematology/oncology fellowship at Roswell Park Center Institute. In addition to his medical degree, Dr. Ahluwalia holds a Master of Business Administration from Case Western Reserve University and the Cleveland Clinic.
He will see patients at Miami Cancer Institute, located at 8900 North Kendall Drive in Miami.
About Baptist Health South Florida
Baptist Health South Florida is the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology program in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.